These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2873002)

  • 21. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease.
    Nishi Y; Lifshitz F; Bayne MA; Daum F; Silverberg M; Aiges H
    Am J Clin Nutr; 1980 Dec; 33(12):2613-21. PubMed ID: 7435430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malnutrition and inflammatory bowel disease.
    Grand RJ
    Curr Concepts Nutr; 1980; 9():125-40. PubMed ID: 6778657
    [No Abstract]   [Full Text] [Related]  

  • 24. Inflammatory bowel disease. Part II.
    Hansen R
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract]   [Full Text] [Related]  

  • 25. Zinc absorption in patients with compensated alcoholic cirrhosis.
    Milman N; Hvid-Jacobsen K; Hegnhøj J; Sørensen SS
    Scand J Gastroenterol; 1983 Oct; 18(7):871-5. PubMed ID: 6676921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
    Das KM; Eastwood MA
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of zinc metabolism in alcoholic cirrhosis.
    Mills PR; Fell GS; Bessent RG; Nelson LM; Russell RI
    Clin Sci (Lond); 1983 May; 64(5):527-35. PubMed ID: 6403278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc concentration in serum and leucocytes in chronic inflammatory diseases.
    Hocke M; Winnefeld K; Bosseckert H
    J Trace Elem Med Biol; 1995 Jul; 9(2):112-6. PubMed ID: 8825984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Serum Trace Element Levels and Superoxide Dismutase Activity in Patients with Inflammatory Bowel Disease: Translating Basic Research into Clinical Application.
    Mohammadi E; Qujeq D; Taheri H; Hajian-Tilaki K
    Biol Trace Elem Res; 2017 Jun; 177(2):235-240. PubMed ID: 27864666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc absorption in alcoholics using zinc-65.
    Dinsmore W; Callender ME; McMaster D; Todd SJ; Love AH
    Digestion; 1985; 32(4):238-42. PubMed ID: 4065445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
    Day JM; Houston JB
    Br J Clin Pharmacol; 1980 Jan; 9(1):91-4. PubMed ID: 6101957
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing nutritional state in inflammatory bowel disease.
    Heatley RV
    Gut; 1986 Nov; 27 Suppl 1(Suppl 1):61-6. PubMed ID: 3539712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the effects of dietary zinc dose on 65Zn absorption in vivo and on the effects of Zn status on 65Zn absorption and body loss in young rats.
    Coppen DE; Davies NT
    Br J Nutr; 1987 Jan; 57(1):35-44. PubMed ID: 3801383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of 65Zn absorption kinetics to intestinal metallothionein in rats: effects of zinc depletion and fasting.
    Hoadley JE; Leinart AS; Cousins RJ
    J Nutr; 1988 Apr; 118(4):497-502. PubMed ID: 3357065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
    Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
    Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
    Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.